SECOND KEY QUESTION: Since withdrawal discomfort is now readily controlled with various medications, so that an addict can be brought without difficulty to an abstinent state, why doesn’t that solve the problem? Why is relapse so common? Is it because of innate deficiencies in the reward pathway, or because chronic exposure to an opiate has caused irreversible changes? In either case, there may be addicts who can not function normally on their own supply of endorphins but require some opiate (like methadone) to occupy the receptors.

We need to know what triggers relapse in an abstinent ex-addict. Relapse is preceded by craving — an irresistible urge to use, often provoked by an environmental cue related to previous use. A cue such as the sight of injection paraphernalia or of a place to buy heroin on the street can not only evoke craving, but can cause measurable physiologic changes like altered pulse, blood pressure, and galvanic skin responses.

A recent study, by researchers at the National Institute on Drug Abuse, concerns craving for cocaine in former cocaine abusers. The method was PET scan, an imaging procedure that shows which areas in the living human brain are activated by certain stimuli. There are two groups of subjects — people who had never used cocaine, and people who had been cocaine abusers in the past but had not used any in recent months. Two kinds of cue were presented on video tape — a neutral one (such as a pastoral scene), and a cocaine-related one (such as injection equipment). Subjects who had never used cocaine showed no unusual brain activity when exposed to either kind of cue. Subjects who had abused cocaine in the past were not affected at all by a neutral cue; but they responded very differently to a cocaine-related cue. Intense craving was provoked, and specific brain areas lit up on the PET scan — areas in parts of the brain (frontal cortex and amygdala) that are known to be associated with emotional memories and craving.

I tell you about this experiment because it shows clearly that in the subjects with previous heavy exposure to cocaine, certain brain regions had been altered by the chronic use of the addictive drug. And it also shows which brain areas are specifically involved in the craving that leads to relapse. Most important for us, it points the way to future similar research with heroin addicts, using brain imaging techniques — an exciting prospect that was only a dream just a few years ago.

Source:
Neurobiology of Heroin Addiction and of Methadone Treatment
By: Avram Goldstein, M.D.
Professor Emeritus of Pharmacology, Stanford University

Visit the aatod conference website for more details…www.aatodconference.com.

@aatod1984
  • 💻Webinar Alert 
11/20, 12:30 PM - 2:00 PM EST
AATOD will present a complimentary webinar on Understanding #Telehealth Induction with #Methadone and #Buprenorphine in OTPs Under the New @samhsagov Regulations.

Mark Parrino, AATOD President, will serve as the host of this webinar along with principal speaker, Dr. Neeraj Gandotra, Chief Medical Officer for SAMHSA.

There will be ample time for Q&A and this webinar will become available to the public for On-Demand viewing via the AATOD website.

Register ➡️ bit.ly/40Kc8LC
  • 🔈AATOD & COMPA on Spectrum News — NY conference highlights new regulations expanding opioid treatment access #OUD #expandingaccesstotreatment
🖥️➡️bit.ly/4eGncNN
  • 💻 Our Association presented a complimentary webinar on the utilization of medications in correctional settings.

#ICYMI, please use this link to view full recording 
⬇️ 
bit.ly/4embfwf
  • 💻 Our Association will present a complimentary webinar on the utilization of medications in correctional settings on September 11, 2024 from 12:00 PM - 1:30 PM EST.

Mark Parrino, AATOD President, will serve as the host along with presenter, Linda Hurley of CODAC Behavioral Healthcare. Ms. Hurley will provide guidance to OTPs on how to work with correctional facilities on how to provide access to #MAT for #OUD.

REGISTER ➡️ bit.ly/3XjZPlV
  • International Overdose Awareness Day (IOAD) – held on August 31 every year – is the world’s largest annual campaign to end overdose, remember without stigma those who have died and acknowledge the grief of family and friends left behind.

The theme for 2024 is “Together we can”, highlighting the power of our community when we all stand together.
#IOAD2024 #TogetherWeCan #EndOverdose

Please view video message from AATOD's President, Mark Parrino ➡️bit.ly/3XpKyRz
  • Welcome to the #aatod2024 Conference
  • Welcome to Las Vegas. We invite you to attend this evening’s AATOD Board meeting ➡️ bit.ly/4apbmVt #aatod2024
  • Join us for the highly acclaimed 8-hour clinician’s course which convenes on Sunday, May 19, 2024 ➡️ bit.ly/3UOKtVi
#aatod2024
  • 📰 AATOD Unites Global Leaders in Opioid Use Disorder Treatment for Pivotal Las Vegas Summit 
➡️https://prn.to/3wEvR2G #OUD #somuchmorethanmedication #aatod2024
  • 💻 Welcome Message from Dr. Dinita Smith, Psy.D, MSW - #aatod2024 Conference Chair 

Thank you to our generous Conference Sponsors, Hosts, Exhibitors, Keynote Speakers, Presenters, Volunteers, and the entire Conference Planning Committee.

Online registration is still available. We look forward to welcoming you to Las Vegas!
💻Webinar Alert 
11/20, 12:30 PM - 2:00 PM EST
AATOD will present a complimentary webinar on Understanding #Telehealth Induction with #Methadone and #Buprenorphine in OTPs Under the New @samhsagov Regulations.

Mark Parrino, AATOD President, will serve as the host of this webinar along with principal speaker, Dr. Neeraj Gandotra, Chief Medical Officer for SAMHSA.

There will be ample time for Q&A and this webinar will become available to the public for On-Demand viewing via the AATOD website.

Register ➡️ bit.ly/40Kc8LC
💻Webinar Alert 11/20, 12:30 PM - 2:00 PM EST AATOD will present a complimentary webinar on Understanding #Telehealth Induction with #Methadone and #Buprenorphine in OTPs Under the New @samhsagov Regulations. Mark Parrino, AATOD President, will serve as the host of this webinar along with principal speaker, Dr. Neeraj Gandotra, Chief Medical Officer for SAMHSA. There will be ample time for Q&A and this webinar will become available to the public for On-Demand viewing via the AATOD website. Register ➡️ bit.ly/40Kc8LC
3 weeks ago
View on Instagram |
1/10
🔈AATOD & COMPA on Spectrum News — NY conference highlights new regulations expanding opioid treatment access #OUD #expandingaccesstotreatment
🖥️➡️bit.ly/4eGncNN
🔈AATOD & COMPA on Spectrum News — NY conference highlights new regulations expanding opioid treatment access #OUD #expandingaccesstotreatment 🖥️➡️bit.ly/4eGncNN
2 months ago
View on Instagram |
2/10
💻 Our Association presented a complimentary webinar on the utilization of medications in correctional settings. #ICYMI, please use this link to view full recording ⬇️ bit.ly/4embfwf
3 months ago
View on Instagram |
3/10
💻 Our Association will present a complimentary webinar on the utilization of medications in correctional settings on September 11, 2024 from 12:00 PM - 1:30 PM EST.

Mark Parrino, AATOD President, will serve as the host along with presenter, Linda Hurley of CODAC Behavioral Healthcare. Ms. Hurley will provide guidance to OTPs on how to work with correctional facilities on how to provide access to #MAT for #OUD.

REGISTER ➡️ bit.ly/3XjZPlV
💻 Our Association will present a complimentary webinar on the utilization of medications in correctional settings on September 11, 2024 from 12:00 PM - 1:30 PM EST. Mark Parrino, AATOD President, will serve as the host along with presenter, Linda Hurley of CODAC Behavioral Healthcare. Ms. Hurley will provide guidance to OTPs on how to work with correctional facilities on how to provide access to #MAT for #OUD. REGISTER ➡️ bit.ly/3XjZPlV
3 months ago
View on Instagram |
4/10
International Overdose Awareness Day (IOAD) – held on August 31 every year – is the world’s largest annual campaign to end overdose, remember without stigma those who have died and acknowledge the grief of family and friends left behind. The theme for 2024 is “Together we can”, highlighting the power of our community when we all stand together. #IOAD2024 #TogetherWeCan #EndOverdose Please view video message from AATOD's President, Mark Parrino ➡️bit.ly/3XpKyRz
3 months ago
View on Instagram |
5/10
Welcome to the #aatod2024 Conference
7 months ago
View on Instagram |
6/10
Welcome to Las Vegas. We invite you to attend this evening’s AATOD Board meeting ➡️ bit.ly/4apbmVt #aatod2024
Welcome to Las Vegas. We invite you to attend this evening’s AATOD Board meeting ➡️ bit.ly/4apbmVt #aatod2024
7 months ago
View on Instagram |
7/10
Join us for the highly acclaimed 8-hour clinician’s course which convenes on Sunday, May 19, 2024 ➡️ bit.ly/3UOKtVi
#aatod2024
Join us for the highly acclaimed 8-hour clinician’s course which convenes on Sunday, May 19, 2024 ➡️ bit.ly/3UOKtVi #aatod2024
7 months ago
View on Instagram |
8/10
📰 AATOD Unites Global Leaders in Opioid Use Disorder Treatment for Pivotal Las Vegas Summit 
➡️https://prn.to/3wEvR2G #OUD #somuchmorethanmedication #aatod2024
📰 AATOD Unites Global Leaders in Opioid Use Disorder Treatment for Pivotal Las Vegas Summit ➡️https://prn.to/3wEvR2G #OUD #somuchmorethanmedication #aatod2024
7 months ago
View on Instagram |
9/10
💻 Welcome Message from Dr. Dinita Smith, Psy.D, MSW - #aatod2024 Conference Chair Thank you to our generous Conference Sponsors, Hosts, Exhibitors, Keynote Speakers, Presenters, Volunteers, and the entire Conference Planning Committee. Online registration is still available. We look forward to welcoming you to Las Vegas!
7 months ago
View on Instagram |
10/10

💻Webinar Alert
11/20, 12:30 PM - 2:00 PM EST.
AATOD will present a complimentary webinar on Understanding #Telehealth Induction with #Methadone and #Buprenorphine in OTPs Under the New @samhsagov Regulations.
Register ➡️ http://bit.ly/40Kc8LC

Load More...

AATOD, Inc.
225 Varick Street, Suite 402
New York, New York 10014

Contact Us
Phone : 212-566-5555
Email : info@aatod.org

Social Sharing
RSS
Follow by Email
Facebook
Twitter
YouTube
LinkedIn
Instagram

Stay Connected to AATOD